Applications of Recombinant DNA Technology in Medicine
Abstract
Full Text:
PDFReferences
M. Venter. Synthetic promoters: genetic control through cis engineering, Trends Plant Sci. 2007; 12(3): 118–24p.
A. Berk, S.L. Zipursky. Molecular Cell Biology. Vol. 4, New York, NY: WH Freeman; 2000.
M. Bazan-Peregrino, R.C.A. Sainson, R.C. Carlisle, et al. Combining virotherapy and angiotherapy for the treatment of breast cancer, Cancer Gene Ther. 2013; 20(8): 461–8p.
L.-X. Li, Y.-L. Zhang, L. Zhou, et al. Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells, J Transl Med. 2013; 11(1): article 257.
C. Méndez, J.A. Salas. On the generation of novel anticancer drugs by recombinant DNA technology: the use of combinatorial biosynthesis to produce novel drugs, Combin Chem – High Through Screen. 2003; 6(6): 513–26p.
B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, D.T. Baird. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency, Hum Reprod Update. 2009; 15(3): 309–21p.
O. Merten, B. Gaillet. Viral vectors for gene therapy and gene modification approaches, Biochem Eng J. 2016; 108: 98–115p
O.-W. Merten, M. Schweizer, P. Chahal, A.A. Kamen. Manufacturing of viral vectors for gene therapy: part I. Upstream processing, Pharm Bioprocess. 2014; 2(2): 183–203p.
S.L. Ginn, I.E. Alexander, M.L. Edelstein, M.R. Abedi, J. Wixon. Gene therapy clinical trials worldwide to 2012 – an update, J Gene Med. 2013; 15(2): 65–77p.
A. Rivero-Müller, S. Lajić, I. Huhtaniemi. Assisted large fragment insertion by Red/ET-recombination (ALFIRE) – an alternative and enhanced method for large fragment recombineering, Nucleic Acids Res. 2007; 35(10): article e78.
DOI: https://doi.org/10.37628/ijaba.v3i1.159
Refbacks
- There are currently no refbacks.